Company Information

Company Profile

CollPlant is a regenerative medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. Our products are based on our recombinant human collagen, that is produced with CollPlant’s proprietary plant based genetic engineering technology.

Our products address indications for the diverse fields of organ and tissue repair, and are ushering in a new era in regenerative medicine. Our flagship rhCollagen BioInk product line is ideal for 3D bioprinting of tissues and organs. In October 2018, we entered into a licensing agreement with United Therapeutics, whereby United Therapeutics is using CollPlant’s BioInks in the manufacture of 3D bioprinted lungs for transplant in humans.

Latest Presentation

Contact Information

Investor Relations
Eran Rotem
Deputy CEO & CFO
T: +972 (73) 2325612
F: +972 (73) 2325602
eran@collplant.com

Corporate Profile®
Laurel Moody
1185 Avenue of the Americas 3rd Floor
New York, NY 10036
T: +1 212 931 8787 Ext 101

Company Contact
CollPlant Biotechnologies Ltd.
4 Oppenheimer St.,
P.O.B 4132
Rehovot 7670104,
Israel